Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 23, 2026
Quotient Sciences said an artificial intelligence algorithm used to select modified-release tablet compositions and doses reached a preset pharmacokinetic target within three dosing periods in an interim clinical study involving healthy participants.
read more
Wednesday, September 23, 2026
ExploRNA Therapeutics and the Lukasiewicz Research Network–Industrial Chemistry Institute have formed a partnership to manufacture ExploRNA’s mRNA cap analogs to good manufacturing practice standards for use in clinical-stage mRNA therapies and ...
read more
Tuesday, September 22, 2026
Kincell Bio and Cellipont Bioservices have completed their merger to form Kincellis Advanced Therapies, a U.S.-based contract development and manufacturing organization focused on cell therapies and other advanced modalities.
read more
Tuesday, September 22, 2026
NanoImaging Services and Proteos have combined under the name TrueCourse Biosciences, creating a U.S.-based contract research organization focused on structural biology, protein science and experimental validation for drug-discovery programs.
read more
Monday, September 21, 2026
mAbxience and Sandoz have signed a licensing, development, manufacturing and commercialization agreement for a proposed biosimilar version of emicizumab, a treatment used for hemophilia A.
read more
Monday, September 21, 2026
Gaelic Laboratories and Athlone Laboratories have aligned their manufacturing processes to offer customers a dual-source supply of oral beta-lactam antibiotics from two Irish production sites following Gaelic’s acquisition of Athlone in December 2025...
read more
Monday, September 21, 2026
Made Scientific has acquired an 85,000-square-foot cell-therapy manufacturing facility in East Norriton, Pennsylvania, from National Resilience, expanding its U.S. East Coast footprint to approximately 145,000 square feet.
read more
Thursday, September 17, 2026
Upperton has received approval from the U.K. Medicines and Healthcare products Regulatory Agency for a variation to its Manufacturing and Importation Authorisation for Investigational Medicinal Products license covering a new sterile manufacturing ...
read more
Wednesday, September 16, 2026
Piramal Pharma Solutions is installing a 4.3-MWp ground-mounted solar power plant at its integrated drug-substance and drug-product facility in Morpeth, United Kingdom.
read more
Wednesday, September 16, 2026
ProBio and Kun Tuo, an IQVIA company, have formed a strategic collaboration to provide development, manufacturing and clinical-operations support for biologics and cell and gene therapies in China.
read more
Wednesday, September 16, 2026
Hovione has opened a 31,000-square-foot facility at its East Windsor, New Jersey, campus, adding two commercial-scale spray dryers and doubling the company’s U.S. spray-drying capacity.
read more
Wednesday, September 16, 2026
Neuland Laboratories has begun operations at the first of four planned modules at its commercial peptide manufacturing site in Hyderabad, India.
read more
Tuesday, September 15, 2026
Ecolab Life Sciences has opened a resin manufacturing facility in Quzhou, China, expanding the company’s capacity to produce materials used in separation, purification and recovery applications.
read more
Tuesday, September 15, 2026
Endpoint Clinical has acquired Bluefin, a provider of clinical supply forecasting and planning technology.
read more
Tuesday, September 15, 2026
FAREVA has acquired a pharmaceutical production site in Lüleburgaz, Türkiye, expanding its manufacturing network and adding nearly 750 employees.
read more